Fanburg-Smith J C, Meis-Kindblom J M, Fante R, Kindblom L G
Department of Soft Tissue Pathology, Armed Forces Institute of Pathology, Washington, DC, USA.
Am J Surg Pathol. 1998 Jul;22(7):779-94. doi: 10.1097/00000478-199807000-00001.
Seventy-three cases of malignant, atypical, and multicentric granular cell tumors of soft tissue were studied to clarify criteria for malignancy and prognostic factors. Six histologic criteria were assessed: necrosis, spindling, vesicular nuclei with large nucleoli, increased mitotic activity (> 2 mitoses/10 high-power fields at 200x magnification), high nuclear to cytoplasmic (N:C) ratio, and pleomorphism. Neoplasms that met three or more of these criteria were classified as histologically malignant; those that met one or two criteria were classified as atypical; and those that displayed only focal pleomorphism but fulfilled none of the other criteria were classified as benign. Hence, 46 cases were classified as histologically malignant, 21 as atypical (3 were multicentric), and 6 as benign (all were multicentric). The patients with benign multicentric and atypical granular cell tumors had no metastases and there were no tumor deaths. In contrast, 11 of 28 patients (39%) with malignant granular cell tumor with follow-up information died of disease at a median interval of 3 years; 8 of 28 (29%) were alive with disease, and 9/28 (32%) were disease free (median intervals, 2 and 7 years, respectively). There were local recurrences in 9 of 28 malignant cases (32%) and metastases in 14 of 28 (50%) (median intervals, each 2 years). Forty-eight cases were studied immunohistochemically; 100% expressed vimentin, 98% S-100 protein, 98% neuron-specific enolase, 69% CD57, and 65% CD68. Alpha-smooth muscle actin, desmin, epithelial membrane antigen (EMA), cytokeratins (with CAM 5.2 and KL-1), chromogranin, and HMB45 were not detected. The proliferative index with Ki67 (MIB 1) was 10-50% in 14 of 25 malignant tumors (56%), and immunostaining for p53 was detected in 50% or more of tumor cells in 17 of 25 (68%); both of these factors were statistically significant with regard to the histologic classification as benign, atypical, or malignant. Ultrastructural examination of 13 benign, atypical, and malignant granular cell tumors showed engorgement of the cytoplasm with complex granules and lysosomes, as well as Schwannian features. By flow cytometric DNA analysis, two of six malignant tumors were aneuploid, two were hyperdiploid, and two were diploid. One atypical tumor was aneuploid and all 11 benign tumors were either diploid (9 cases) or hyperdiploid (2 cases). Statistically significant adverse prognostic factors with regard to survival included local recurrence, metastasis, larger tumor size, older patient age, histologic classification as malignant, presence of necrosis, increased mitotic activity, spindling of tumor cells, vesicular nuclei with large nucleoli, and Ki67 values greater [corrected] than 10%. This study defines clinical and morphologic criteria for malignancy in granular cell tumors and shows that malignant granular cell tumor is a high-grade sarcoma with a high rate of metastases and a short survival.
对73例软组织恶性、非典型及多中心性颗粒细胞瘤进行研究,以明确恶性标准和预后因素。评估了6项组织学标准:坏死、梭形化、核呈空泡状且核仁大、有丝分裂活性增加(在200倍放大倍数下,每10个高倍视野中>2个有丝分裂象)、高核质比以及多形性。符合3项或更多这些标准的肿瘤被分类为组织学恶性;符合1项或2项标准的肿瘤被分类为非典型;仅表现为局灶性多形性但不符合其他任何标准的肿瘤被分类为良性。因此,46例被分类为组织学恶性,21例为非典型(3例为多中心性),6例为良性(均为多中心性)。良性多中心性和非典型颗粒细胞瘤患者无转移,也无肿瘤死亡病例。相比之下,28例有随访信息的恶性颗粒细胞瘤患者中有11例(39%)在中位间隔3年后死于疾病;28例中有8例(29%)带瘤存活,9/28(32%)无病生存(中位间隔分别为2年和7年)。28例恶性病例中有9例(32%)出现局部复发,14例(50%)出现转移(中位间隔均为2年)。对48例进行了免疫组织化学研究;100%表达波形蛋白,98%表达S-100蛋白,98%表达神经元特异性烯醇化酶,69%表达CD57,65%表达CD68。未检测到α-平滑肌肌动蛋白、结蛋白、上皮膜抗原(EMA)、细胞角蛋白(采用CAM 5.2和KL-1)、嗜铬粒蛋白和HMB45。25例恶性肿瘤中有14例(56%)的Ki67(MIB 1)增殖指数为10% - 50%,25例中有17例(68%)的肿瘤细胞中有50%或更多检测到p53免疫染色;这两个因素在组织学分类为良性、非典型或恶性方面均具有统计学意义。对13例良性、非典型和恶性颗粒细胞瘤进行超微结构检查显示,细胞质内充满复杂颗粒和溶酶体,以及施万细胞特征。通过流式细胞术DNA分析,6例恶性肿瘤中有2例为非整倍体,2例为超二倍体,2例为二倍体。1例非典型肿瘤为非整倍体,11例良性肿瘤均为二倍体(9例)或超二倍体(2例)。与生存相关的具有统计学意义 的不良预后因素包括局部复发、转移、肿瘤体积较大、患者年龄较大、组织学分类为恶性、存在坏死、有丝分裂活性增加、肿瘤细胞梭形化、核呈空泡状且核仁大以及Ki67值大于10%[校正后]。本研究确定了颗粒细胞瘤恶性的临床和形态学标准,并表明恶性颗粒细胞瘤是一种高级别肉瘤,转移率高,生存期短。